Dr William Kilgallon is the CEO of Xantho Ventures and Cybex Ventures, both Biotech/Medtech consultancy and venture capital companies. He has over 30 years’ experience in the healthcare sector encompassing SME and multi-national companies in UK, Europe, USA, Asia Pacific and Japan, working in a range of roles up to senior vice president level. He holds a first degree in Pharmacology, a PhD in Immunology and a MBA specialising in Business Transformation. Dr Kilgallon has completed a wide range of entrepreneurial projects including MBOs, Turnarounds, Trade Sales and Investments. He has recently completed a Royal Society Entrepreneur in Residence programme, has created university spinouts, and lectures on a Biotech MBA course at the Donau University, Austria where he holds a Professorship.